Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)

13 filings reported holding GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share as of Q1 2025.
Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55.9K shares of 5.59M outstanding shares and own 1% of the company stock.
Largest 10 shareholders include Schonfeld Strategic Advisors LLC (25.2K shares), Virtu Financial LLC (11.1K shares), TWO SIGMA SECURITIES, LLC (11K shares), MORGAN STANLEY (7.39K shares), UBS Group AG (1.1K shares), SBI Securities Co., Ltd. (16 shares), Federation des caisses Desjardins du Quebec (14 shares), WELLS FARGO & COMPANY/MN (9 shares), OSAIC HOLDINGS, INC. (5 shares), and Allworth Financial LP (2 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.